Replimune
REPL
#4939
Rank
HK$14.17 B
Marketcap
HK$149.48
Share price
-0.83%
Change (1 day)
108.78%
Change (1 year)

EPS for Replimune (REPL)

EPS in 2026 (TTM): -HK$22.88

According to Replimune 's latest financial reports the company's current EPS (TTM) is -HK$22.97. a decrease over its 2025 EPS that were of -HK$24.06.

EPS history for Replimune from 2017 to 2026

Annual EPS

Year EPS Change
2026-HK$26.4910.1%
2025-HK$24.06-5.25%
2024-HK$25.408.36%
2023-HK$23.4432.3%
2022-HK$17.7229.14%
2021-HK$13.7213.64%
2020-HK$12.0715.79%
2019-HK$10.4345.18%
2018-HK$7.18155.74%
2017-HK$2.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58-53.92%๐Ÿ‡บ๐Ÿ‡ธ USA